Trial
NCT05124795
IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate Cancer
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Immunic AG
Collaborators
—
Condition
Metastatic Castration Resistant Prostate Cancer
Intervention
IMU-935
Why stopped
Lack of Efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-01-17